Dysfunctional Decidual CD4 + T Cells Induce Recurrent Pregnancy Loss via Palmitoylation‐Dependent Tim‐3 Lysosomal Sorting and Degradation
Advanced Science · 2025
DOI: 10.1002/advs.202500971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Liyuan Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Fudan University Shanghai Medical College, Shanghai, 200092, China. Hauptthemen laut MEDLINE: Lipoylation, Hepatitis A Virus Cellular Receptor 2, Abortion, Habitual, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Nature Science Foundation of China, Special Youth Project for Clinical Research in Health Industry of Shanghai Municipal Health Commission.
Abstract (Originalsprache)
Palmitoylation is a fully reversible post‐translational modification that regulates the functions of various proteins. While its dysregulation has been implicated in numerous pathological processes, there has been scarce researches on palmitoylation changes in proteins associated with recurrent pregnancy loss (RPL). Utilizing palmitoylation proteomics, 3262 proteins are identified with increased palmitoylation and 1577 proteins with decreased palmitoylation in the decidual immune cells from RPL patients compared to those from normal early pregnancies. Reduced palmitoylation by 2‐bromopalmitate promoted decidual CD4 + T (dCD4 + T) cell tolerance and decrease the resorption rate of abortion‐prone mice, suggesting that elevated palmitoylation level may be associated with RPL. The bioinformatics, proteomic, functional and mouse model studies revealed that T cell immunoglobulin domain and mucin domain‐3 (Tim‐3) is palmitoylated by ZDHHC3 on cysteine 9 residue. This palmitoylated‐Tim‐3 subsequently bound to sortilin and was directed to lysosome for degradation, leading to decreased expression of Tim‐3 and the dysfunction of dCD4 + T cells, ultimately resulting in fetal loss. We elucidated a pivotal role for dynamic palmitoylation in RPL and uncovered a novel mechanism governing Tim‐3 regulation. Given that Tim‐3 dysregulation is frequently linked to RPL, our findings may have important implications for understanding the etiology of RPL and developing targeted therapy of RPL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Fudan University Shanghai Medical College, Shanghai, 200092, China.
- Department of Interventional Vascular Surgery, Xinhua Hospital, Shanghai JiaoTong University, School of Medicine, Shanghai, 200090, China.
ORCID-Profile: Songcun Wang
Förderung
- National Key Research and Development Program of China
- National Nature Science Foundation of China
- Special Youth Project for Clinical Research in Health Industry of Shanghai Municipal Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Cui, L., Meng, X., Luo, Y., Qian, J., Sun, F., Qiu, M., & Wang, S. (2025). Dysfunctional Decidual CD4 + T Cells Induce Recurrent Pregnancy Loss via Palmitoylation‐Dependent Tim‐3 Lysosomal Sorting and Degradation. Advanced Science. https://doi.org/10.1002/advs.202500971
Vancouver
Cui L, Meng X, Luo Y, Qian J, Sun F, Qiu M, et al. Dysfunctional Decidual CD4 + T Cells Induce Recurrent Pregnancy Loss via Palmitoylation‐Dependent Tim‐3 Lysosomal Sorting and Degradation. Advanced Science. 2025. doi:10.1002/advs.202500971
BibTeX
@article{Cui2025,
author = {Cui, Liyuan and Meng, Xinhang and Luo, Yujie and Qian, Jinfeng and Sun, Fengrun and Qiu, Mingke and Wang, Songcun},
title = {Dysfunctional Decidual CD4 + T Cells Induce Recurrent Pregnancy Loss via Palmitoylation‐Dependent Tim‐3 Lysosomal Sorting and Degradation},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500971}
}
EUVIMED